Abstract:Aim: To provide further foundation for the therapy for ischemic heart diseases by transferred bone mesenchymal cells with the recombinant plasmid coding vascular endothelial growth factor by lipofectamine. Methods: The experiment was conducted at the laboratory of Medical Genetics, Second Military Medical University of Chinese PLA and the laboratory of Department of Cardiology, Shanghai First People's Hospital of Shanghai Jiao Tong University from July 2004 to March 2005. 1 Bone mesenchymal stem cells were isolated from rat and directly cultivated and expanded in vitro. 2 Bone mesenchymal cells were divided into 3 groups: PcDNA3.1-VEGF transferred group; PcDNA3.1 transferred group and untransfected group. 3 The supernatant of each group was collected at day 1, 3, 5, 7, 9, 11 to detect the subsequent protein expression of vascular endothelial growth factor by ELISA method. Western blotting was applied to assay the expression of transgenic bone mesenchymal stem cells cultured in L-DMEM containing G418. MTT method was applied to assay the mitogenic effect of expression of vascular endothelial growth factor on bone mesenchymal stem cells. Results: 1 Immunohistochemistry showed CD106 was positive and CD34 was negative. 2 ELISA suggested that one day after the beginning of transfection, the concentration of vascular endothelial growth factor in the supernatant of medium was significantly increased, and reached its peak at the fifth day, then it gradually decreased and kept stable ten days later, but still higher than that of the control group. 3 Western blot showed that the vascular endothelial growth factor protein of the PcDNA3.1-VEGF transfected group was higher than that in PcDNA3.1 transfected group and untransfected group. 4 MTT showed that the expression of vascular endothelial growth factor could improve the proliferation of bone mesenchymal stem cells. Conclusion: The plasmid vector coding vascular endothelial growth factor gene is successfully transfected into bone mesenchymal stem cells. The expression of vascular endothelial growth factor improves the proliferation of bone mesenchymal stem cells, which enable us combine gene therapy and stem cells transplantation together.

Transfection of vascular endothelial growth factor gene in improving the proliferation of bone mesenchymal stem cells